Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations

References

• Wu J , YangS , XuKet al. Patterns and trends of liver cancer incidence rates in eastern and southeastern Asian countries (1983–2007) and predictions to 2030. Gastroenterology154(6), 1719–1728.e1715 (2018).
   PubMed Web of Science ®Google Scholar
• Sia D , VillanuevaA , FriedmanSL , LlovetJM. Liver cancer cell of origin, molecular class and effects on patient prognosis. Gastroenterology152(4), 745–761 (2017).
   PubMed Web of Science ®Google Scholar
• Colagrande S , InghilesiAL , AburasS , TalianiGG , NardiC , MarraF. Challenges of advanced hepatocellular carcinoma. World J. Gastroenterol.22(34), 7645–7659 (2016).
   PubMed Web of Science ®Google Scholar
• Dimitroulis D , DamaskosC , ValsamiSet al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J. Gastroenterol.23(29), 5282–5294 (2017).
   PubMed Web of Science ®Google Scholar
• Jiang Y , SunA , ZhaoYet al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature567(7747), 257–261 (2019).
   PubMed Web of Science ®Google Scholar
• Chaisaingmongkol J , BudhuA , DangHet al. Common molecular subtypes among asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell32(1), 57–70.e53 (2017).
   PubMed Web of Science ®Google Scholar
• Mirzaei HR , SahebkarA , MohammadiMet al. Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers. Curr. Pharm. Design22(34), 5257–5269 (2016).
   PubMed Web of Science ®Google Scholar
• Naeli P , PourhanifehMH , KarimzadehMRet al. Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit. Rev. Oncol./Hematol.145, 102854 (2020).
   PubMed Web of Science ®Google Scholar
• Alaei-Mahabadi B , BhaduryJ , KarlssonJW , NilssonJA , LarssonE. Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. Proc. Natl Acad. Sci. USA113(48), 13768–13773 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou C , BiF , YuanJ , YangF , SunS. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6. J. Exp. Clin. Cancer Res.37(1), 290 (2018).
   PubMedGoogle Scholar
• Gu DL , ChenYH , ShihJH , LinCH , JouYS , ChenCF. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma. World J. Gastroenterol.19(47), 8873–8879 (2013).
   PubMed Web of Science ®Google Scholar
• Du Z , FeiT , VerhaakRGet al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol.20(7), 908–913 (2013).
   PubMed Web of Science ®Google Scholar
• Conrad DF , PintoD , RedonRet al. Origins and functional impact of copy number variation in the human genome. Nature464(7289), 704–712 (2010).
   PubMed Web of Science ®Google Scholar
• Silva GO , HeX , ParkerJSet al. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Breast Cancer Res. Treat.152(2), 347–356 (2015).
   PubMed Web of Science ®Google Scholar
• Jarroux J , MorillonA , PinskayaM. History, discovery and classification of lncRNAs. Adv. Exp. Med. Biol.1008, 1–46 (2017).
   PubMed Web of Science ®Google Scholar
• Schmitt AM , ChangHY. Long noncoding RNAs in cancer pathways. Cancer Cell29(4), 452–463 (2016).
   PubMed Web of Science ®Google Scholar
• Vafadar A , ShabaninejadZ , MovahedpourAet al. Long noncoding RNAs as epigenetic regulators in cancer. Curr. Pharm. Design25(33), 3563–3577 (2019).
   PubMed Web of Science ®Google Scholar
• Begolli R , SiderisN , GiakountisA. LncRNAs as chromatin regulators in cancer: from molecular function to clinical potential. Cancers11(10), 1524 (2019).
   PubMed Web of Science ®Google Scholar
• Wang Q , JiaP , LiFet al. Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med.5(10), 91 (2013).
   PubMedGoogle Scholar
• Guichard C , AmaddeoG , ImbeaudSet al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genet.44(6), 694–698 (2012).
   PubMed Web of Science ®Google Scholar
• Huarte M . The emerging role of lncRNAs in cancer. Nat. Med.21(11), 1253–1261 (2015).
   PubMed Web of Science ®Google Scholar
• Cui H , ZhangY , ZhangQ , ChenW , ZhaoH , LiangJ. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma. Cancer Med.6(12), 2932–2941 (2017).
   PubMed Web of Science ®Google Scholar
• Volders PJ , LefeverS , BauteSet al. Targeted genomic screen reveals focal long noncoding RNA copy number alterations in cancer cell lines. Noncoding RNA4(3), 21 (2018).
   PubMedGoogle Scholar
• Zhang Y , XuH , FrishmanD. Genomic determinants of somatic copy number alterations across human cancers. Hum. Mol. Genet.25(5), 1019–1030 (2016).
   PubMed Web of Science ®Google Scholar
• Lee JT . Epigenetic regulation by long noncoding RNAs. Science338(6113), 1435–1439 (2012).
   PubMed Web of Science ®Google Scholar
• Wang H , LiangL , FangJY , XuJ. Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene35(16), 2011–2019 (2016).
   PubMed Web of Science ®Google Scholar
• Qin LX , TangZY , ShamJSet al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res.59(22), 5662–5665 (1999).
   PubMed Web of Science ®Google Scholar
• Yang Y , ChenL , GuJet al. Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat. Commun.8, 14421 (2017).
   PubMed Web of Science ®Google Scholar
• Jariwala N , SarkarD. Emerging role of lncRNA in cancer: a potential avenue in molecular medicine. Ann. Transl. Med.4(15), 286 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao W , MaX , LiuLet al. SNHG20: a vital lncRNA in multiple human cancers. J. Cell. Physiol.234(9), 14519–14525 (2019).
   PubMed Web of Science ®Google Scholar
• Chen Z , ChenX , ChenPet al. Long noncoding RNA SNHG20 promotes non-small-cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death Dis.8(10), e3092 (2017).
   PubMedGoogle Scholar
• Zhang D , CaoC , LiuL , WuD. Up-regulation of LncRNA SNHG20 predicts poor prognosis in hepatocellular carcinoma. J. Cancer7(5), 608–617 (2016).
   PubMed Web of Science ®Google Scholar
• Bermudo R , AbiaD , FerrerBet al. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer8, 315 (2008).
   PubMed Web of Science ®Google Scholar
• Sunpaweravong P , ThuKL , LamWL , MaiS. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients. J. Cancer Res. Clin. Oncol.142(4), 749–756 (2016).
   PubMed Web of Science ®Google Scholar
• Saito H , InazawaJ , SaitoSet al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res.53(14), 3382–3385 (1993).
   PubMed Web of Science ®Google Scholar
• Zhang Y , TaoY , LiYet al. The regulatory network analysis of long noncoding RNAs in human colorectal cancer. Funct. Integr. Genomics18(3), 261–275 (2018).
   PubMed Web of Science ®Google Scholar
• Liu X , ZhuQ , GuoY , XiaoZ , HuL , XuQ. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis. Biomed. Pharmacother.117, 109069 (2019).
   PubMed Web of Science ®Google Scholar
• Nie JH , LiTX , ZhangXQ , LiuJ. Roles of noncoding RNAs in normal human brain development, brain tumor and neuropsychiatric disorders. Noncoding RNA5(2), 36 (2019).
   PubMed Web of Science ®Google Scholar